Natural products and cardiovascular disturbances

Phytotherapy Research

Volumn 12, Issue SUPPL. 1, 1998, Pages

  Mascolo, N ^a   Borrelli, F ^a   Capasso, R ^a   Capasso, F ^a   Di Carlo, G ^a   Izzo, A A ^a   Pinto, L ^a   Castaldo, S ^b   Longo, R ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b INPS Nola   (Italy)

^c C Sessa Pharmaceutical Laboratories   (Italy)

Author keywords

Angina; Ginkgo; Hawthorn; Horse chestnut; Peripheral vascular disease

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; GINKGO BILOBA EXTRACT;

ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; CRATAEGUS; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; HUMAN; NONHUMAN; PERIPHERAL VASCULAR DISEASE; RISK BENEFIT ANALYSIS;

EID: 0031711360     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1573(1998)12:1+3.0.CO;2-8     Document Type: Conference Paper

References (31)

1. Al-Makdessi, S., Sweidan, H., Mullner, S., and Jacob, R. (1996). Myocardial protection by pretreatment with Crataegus oxycantha: an assessment by means of the release of lactate deydrogenase by the ischemic and reperfused Langendorff heart. Arzneimittelforschung. 46, 25-27.
2. Ammon, H. P. T., and Handel, M. (1981a). Crataegus, toxicology and pharmacology. Part I Toxicity. Planta Med. 43, 105-120.
3. Ammon, H. P. T., and Handel, M. (1981b). Crataegus, toxicology and pharmacology. Part III: Pharmacodynamics and pharmacokinetics. Planta Med. 43, 313-322.
4. Blume, J., Kieser, M., and Holscher, U. (1996). Placebo-controlled double-blind study of effectiveness of Gingko biloba special extract Egb 761 in trained patients with intermittent claudication. Vasa 25, 265-274
5. Braquet, P. (1987). The ginkgolides: potent platelet-activating factor antagonists isolated from Gingko biloba L.: Chemistry, pharmacology and clinical applications. Drugs of the Future 12, 643-699.
6. Diehm, C., Trampisch, H. J., Lange, S., and Schmidt, C. (1996). Comparison of leg compression stocking and oral horse chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 347, 292-294.
7. Eckmann, F. (1990). Cerebral insufficiency treatment with Ginkgo-biloba extract. Time of onset of effect in a double-blind study with 60 patients. Fortschr. Med. 108, 557-560.
8. Greeske, K., and Pohlmann, B. K. (1996). Horse chestnut seed extract an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency. Fortschr. Med. 114, 196-200.
9. Haas, H. (1991). Arzneipflanzenkunde, pp. 13-17. B.I. Wissenschaftsverlag, Mannheim.
10. Hanak, T., and Bruckel, M. H. (1983). Behandlung von leichten stabilen Formen der angina pectoris mit Crataegutt novo. Therapiewoche 33, 4331-4333.
11. Hänsel, R. (1991). Phytopharmaka, 2nd edn, pp. 59-72. Springer Verlag, Berlin.
12. Hindmarsh, S. Z. (1984). The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers. Int. J. Clin. Pharmacol. Res. 4, 89-93.
13. Hopfenmuller, W. (1994). Evidence for a therapeutic effect of Gingko biloba special extract. Meta-analysis of 11 clinical studies in patients with cerebrovascular insufficiency in old age. Arzneimittelforschung. 44, 1005-1013.
14. Iwamoto, M., Ishizaki, T., Sato, T. et al. (1981). Klinische wirkung von Crataegutt bei Herzerkrankungen ischamischer und/oder hypertensiver Genese. Planta Med. 42, 1-16.
15. Izzo, A. A. (1996). PAF and the digestive tract. A review. J. Pharm. Pharmacol. 48, 1103-1111.
16. Koltringer, P., Langsteger, W., Klima, G., Reisecker, F., and Eber, O. (1993). Hemorheologic effects of Gingko biloba extract Egb 761. Dose-dependent effect of Egb 761 on microcirculation and viscoelasticity of blood. Fortschr. Med. 111, 170-172.
17. Marchetti, G. (1993). Digitalis in heart failure today. In, Experimental Cardiology, ed. by C. Casagrande, pp. 283-296. Ed. Sci., Milano.
18. Mouren, X., Caillard, P., and Schwartz, F. (1994). Study of the antiischemic action of Egb 761 in the treatment of peripheral arterial occlusive disease by TcPo2 determination. Angiology 45, 413-417.
19. Nasa, Y., Hashizume, H., Hoque, A. N., and Abiko, Y. (1993). Protective effect of crataegus extract on the cardiac mechanical dysfunction in isolated perfused working rat heart. Arzneimittelforschung. 43, 945-949.
20. Newall, C. A., Anderson, L. A., and Phillipson, J. D. (1996). Herbal Medicines. The Pharmaceutical Press, London.
21. Petkow, V. (1979). Plants with hypotensive, antiatheromatous and coronarodilatating action. Am.J.Chin. Med. 7, 197-236.
22. Pizzorno, J. E., and Murray, M. T. (1985). A Texbook of Natural Medicine, ed. by W.A. Scottle John Bastyr College Publications.
23. Raabe, A., Raabe, M., and Ihm, P. (1991). Therapeutic followup using automatic perimetry in chronic cerebroretinal ischemia in elderly patients. Prospective double-blind study with graduated dose Gingko biloba treatment (Egb 761). Klin. Monatsbl. Augenheilkd 199, 432-438.
24. Rehn, D., Unkauf, M., Klein, P., Jost, V., and Lunker, P. W. (1996). Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneimittelforschung. 46, 483-487.
25. Thompson, E. B., Anynilian, G. H., Gora, P., and Farnsworth, R. (1974). Preliminary study of potential antiarrhythmic effects of Crataegus monogyna. J. Pharm. Sci. 63, 1936-1937.
26. Tsutsumi, S., and Ishizuka, S. (1967). Antiinflammatory effects of the extract Aesculus hippocastanum and seed. Shikwa-Gakutto 67, 1324-1328.
27. Tyler, V. E. (1993). Herbs of Choice. Pharmaceutical Products Press, New York.
28. Vorberg, G. (1985). Ginkgo biloba extract (GBE): a long term study on chronic cerebral insufficiency in geriatric patients. Clin. Trials J. 22, 149-157.
29. Weihmayr, T., and Ernst, E. (1996). Therapeutic effectiveness of Crataegus. Fortschr. Med. 114, 27-29.
30. Weikl, A., Assmus, K. D., Neukum-Schmidt, A. et al. (1996). Crataegus-spezialextrakt WS 1442. Objektiver wirksamkeitsnachweis bei patienten mit Herzinsuffizienz (NYHA II). Fortschr. Med. 114, 291-296.
31. Witte, S., Anadere, I., and Walitza, E. (1992). Improvement of hemorheology with Gingko biloba extract. Decreasing a cardiovascular risk factor. Fortschr. Med. 110, 247-250.